F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
Patients with one of the deadliest cancers have been pleading [...]
The early FDA approval doesn’t…
The early FDA approval doesn’t change Pfizer and Arvinas’ plan [...]
Top Psychiatrists Call for a Greater Focus on Ceasing Medication
With Health Secretary Robert F. Kennedy Jr. aiming to rein [...]
Katherine Szarama, Ph.D., will…
Katherine Szarama, Ph.D., will take over as CBER director in [...]
Viking Therapeutics’…
Viking Therapeutics’ collaboration with Ligand Pharmaceuticals has sailed into some [...]
Johnson & Johnson has dropped…
Johnson & Johnson has dropped a pair of CAR-T cell [...]
An FDA expert panel on Thursday…
An FDA expert panel on Thursday voted 6 to 3 [...]
As Eli Lilly gets off to the races…
As Eli Lilly gets off to the races with the [...]
Bristol Myers Squibb’s growth…
Bristol Myers Squibb’s growth portfolio is offsetting declines in older [...]
While Merck’s PAH treatment…
While Merck’s PAH treatment Winrevair continued its upward trajectory, another [...]